WHWK
Whitehawk Therapeutics Inc
NASDAQ · Healthcare · Biotechnology · US
$4.60
−0.65%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+9.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 30, 2026 | Dalal Anupam · director | A-Award | 38,040 | $4.16 |
| Jul 30, 2026 | Dalal Anupam · director | A-Award | 1,275,510 | $3.92 |
| Jun 15, 2026 | Reeve Emma · director | A-Award | 38,040 | $4.16 |
| Jun 15, 2026 | Zhao Baiteng · director | A-Award | 38,040 | $4.16 |
| Jun 15, 2026 | Aghazadeh Behzad · director, 10 percent owner, other: See remarks | A-Award | 38,040 | $4.16 |
| Jun 15, 2026 | Castelein Caley · director | A-Award | 38,040 | $4.16 |
| Jun 15, 2026 | Desai Neil · director | A-Award | 38,040 | $4.16 |
| Jun 15, 2026 | Hirmand Mohammad · director | A-Award | 38,040 | $4.16 |
| Jun 15, 2026 | Maroun Richard E · director | A-Award | 38,040 | $4.16 |
| May 18, 2026 | Castelein Caley · director | A-Award | 255,102 | $3.92 |
| May 18, 2026 | BALL BRYAN · officer: See remarks | A-Award | 51,020 | $3.92 |
| May 18, 2026 | Castelein Caley · director | A-Award | 2,072,756 | $0.00 |
| May 18, 2026 | Dugan Margaret · officer: Chief Medical Officer | A-Award | 19,132 | $3.92 |
| May 18, 2026 | Lennon David James · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 51,021 | $3.92 |
| May 18, 2026 | Giacobello Scott M. · officer: CHIEF FINANCIAL OFFICER | A-Award | 38,265 | $3.92 |
| May 14, 2026 | Avoro Capital Advisors LLC · director, 10 percent owner, other: See Remarks | A-Award | 6,377,714 | $0.00 |
| Apr 17, 2026 | Giacobello Scott M. · officer: CHIEF FINANCIAL OFFICER | Sale | 141,600 | $4.13 |
| Apr 17, 2026 | Giacobello Scott M. · officer: CHIEF FINANCIAL OFFICER | Sale | 77,000 | $3.86 |
| Apr 15, 2026 | BALL BRYAN · officer: See remarks | Sale | 26,389 | $3.46 |
| Apr 15, 2026 | BALL BRYAN · officer: See remarks | Sale | 92,460 | $3.64 |
| Apr 13, 2026 | BALL BRYAN · officer: See remarks | Sale | 50,000 | $3.57 |
| Apr 13, 2026 | BALL BRYAN · officer: See remarks | Sale | 6,596 | $3.43 |
| Apr 10, 2026 | Lennon David James · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 14,500 | $3.38 |
| Apr 8, 2026 | Lennon David James · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 94,087 | $3.43 |
| Apr 8, 2026 | Lennon David James · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 63,945 | $3.40 |
| Apr 8, 2026 | Lennon David James · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 102,395 | $3.51 |
| Apr 3, 2026 | Lennon David James · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 831,148 | $3.54 |
| Apr 3, 2026 | Dornan David · officer: Chief Scientific Officer | A-Award | 282,340 | $3.54 |
| Apr 3, 2026 | Dugan Margaret · officer: Chief Medical Officer | A-Award | 283,157 | $3.54 |
| Apr 3, 2026 | BALL BRYAN · officer: See remarks | M-Exempt | 366,532 | $0.00 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 30, 2026